Yatharth Hospital & Trauma Care Services Limited (BOM:543950)

Market Cap	82.59B +37.0%
Revenue (ttm)	12.33B +39.2%
Net Income	1.75B +34.3%
EPS	18.20 +23.6%
Shares Out	n/a
PE Ratio	47.09
Forward PE	34.09
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,949
Open	849.05
Previous Close	843.30
Day's Range	844.95 - 860.60
52-Week Range	538.15 - 889.80
Beta	n/a
Analysts	Strong Buy
Price Target	998.50 (+17.64%)
Earnings Date	Aug 11, 2026

About BOM:543950

Yatharth Hospital & Trauma Care Services Limited, together with its subsidiaries, owns and operates super-specialty hospitals in India. The company offers services in the areas of medicine, cardiology, neurosciences, general surgery, nephrology and urology, pediatrics, gastroenterology, pulmonology, gynecology, orthopedics, spine and rheumatology, plastic and cosmetic surgery, ear, nose, throat, endocrinology, critical care, dermatology, nuclear medicine, and cancer and bone marrow transplant. It also provides services in the areas of GI surger...

• Industry: Hospitals
• Founded: 2008
• Employees: 4,895
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 543950

Financial Performance

In fiscal year 2026, BOM:543950's revenue was 12.33 billion, an increase of 39.22% compared to the previous year's 8.86 billion. Earnings were 1.75 billion, an increase of 34.34%.

Analyst Summary

According to 4 analysts, the average rating for 543950 stock is "Strong Buy." The 12-month stock price target is ₹998.50, which is an increase of 17.64% from the latest price.

Price Target

₹998.50

(17.64% upside)

Analyst Consensus: Strong Buy

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jul 21, 2026

Data Sources Report a data error